Key result
Electroconvulsive therapy was discussed in the context of 3 unusual cases involving treatment resistance, polymyositis, and severe neuroleptic malignant syndrome.
Answers are grounded in this paper and cite their sources.
Highlights the importance of case reports and expert consultation for guiding ECT use in rare or complex clinical scenarios lacking trial evidence.
Well-established practice guidelines and a solid body of evidence underpin the safe and effective use of electroconvulsive therapy (ECT), primarily in mood disorders. In this issue of the journal, 3 case reports deal with situations that fall outside of the usual guidelines: treatment resistance to ECT overcome by combined use with antidepressant medication; use of ECT in the presence of polymyositis; and use of ECT for an unusually severe case of neuroleptic malignant syndrome, assisted by consultation from an online expert resource. The value of case reports and expert consultation in situations in which there is little or no evidence from clinical trials is also discussed.
No takes yet. Share an insight, caveat, or question.
David Kahn (2016) conducted an editorial in Mood disorders, polymyositis, neuroleptic malignant syndrome (n=3). Electroconvulsive therapy (ECT) was evaluated. Electroconvulsive therapy was discussed in the context of 3 unusual cases involving treatment resistance, polymyositis, and severe neuroleptic malignant syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: